EP Patent

EP1381600A1 — Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan

Assigned to Wyeth LLC · Expires 2004-01-21 · 22y expired

What this patent protects

Compounds of the formula (I), useful for the treatment of depression and other conditions such as obsessive compulsive disorder, panic attacks, generalized anxiety disorder, sexual dysfunction, eating disorders, addictive disorders caused by ethanol or cocaine abuse and related i…

USPTO Abstract

Compounds of the formula (I), useful for the treatment of depression and other conditions such as obsessive compulsive disorder, panic attacks, generalized anxiety disorder, sexual dysfunction, eating disorders, addictive disorders caused by ethanol or cocaine abuse and related illnesses.

Drugs covered by this patent

Patent Metadata

Patent number
EP1381600A1
Jurisdiction
EP
Classification
—
Expires
2004-01-21
Drug substance claim
No
Drug product claim
No
Assignee
Wyeth LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.